These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2009144)

  • 1. Characteristics of a new angiotensin converting enzyme inhibitor: delapril.
    Saruta T; Nishikawa K
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):23S-28S. PubMed ID: 2009144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Razzetti R; Acerbi D
    Am J Cardiol; 1995 Jun; 75(18):7F-12F. PubMed ID: 7778536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of delapril in hypertensive patients along the cardiovascular continuum.
    González-Juanatey JR; Cordero A
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):271-81. PubMed ID: 23469905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex.
    Ogihara T; Mikami H; Katahira K; Otsuka A
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):46S-51S. PubMed ID: 2009148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
    Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat.
    Mizuno K; Tani M; Niimura S; Yamaguchi M; Inagami T; Fukuchi S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):60S-66S. PubMed ID: 2009151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dry cough in the elderly patients treated with angiotensin converting enzyme inhibitor].
    Kaku T; Yamasaki H; Harada N; Tsujino M; Inoue G
    Nihon Ronen Igakkai Zasshi; 1991 May; 28(3):365-70. PubMed ID: 1895531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the magnitude and the mechanism of cough potentiation by angiotensin-converting enzyme inhibitors in guinea-pigs: involvement of bradykinin in the potentiation.
    Takahama K; Araki T; Fuchikami J; Kohjimoto Y; Miyata T
    J Pharm Pharmacol; 1996 Oct; 48(10):1027-33. PubMed ID: 8953504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat.
    Morishita R; Higaki J; Nakamura F; Tomita N; Yu H; Nagano M; Mikami H; Ogihara T
    Blood Press Suppl; 1992; 3():41-7. PubMed ID: 1343288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril.
    Ogihara T; Kaneko Y; Ikeda M; Yamada K; Omae T; Arakawa K; Ishii M; Yoshinaga K; Kumahara Y; Kokubu T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):42S-45S. PubMed ID: 2009147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of delapril hydrochloride on the myocardium of spontaneously hypertensive rats.
    Takeda N; Iwai T; Tanamura A; Nakamura I; Nagano M
    Can J Cardiol; 1994 Nov; 10(9):939-43. PubMed ID: 7954031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.
    Natoff IL; Nixon JS; Francis RJ; Klevans LR; Brewster M; Budd J; Patel AT; Wenger J; Worth E
    J Cardiovasc Pharmacol; 1985; 7(3):569-80. PubMed ID: 2410692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delapril hydrochloride on angiotensin II release from isolated rat hind legs.
    Mizuno K; Niimura S; Tani M; Fukuchi S; Inagami T
    Eur J Pharmacol; 1990 Aug; 184(1):169-72. PubMed ID: 2209711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure and metabolic response to converting enzyme inhibitor in hypertensive patients: comparison between delapril and captopril].
    Chu TS; Wu MS; Chen YM; Wu KD
    J Formos Med Assoc; 1992 Dec; 91 Suppl 4():S288-92. PubMed ID: 1363526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of delapril combined with indapamide or hydrochlorothiazide in spontaneously hypertensive stroke-prone rats: a comparative dose-response analysis.
    Boschi S; Vantaggiato G; Torri C; Zini I; Agnati LF; Zoli M; Biagini G
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):321-8. PubMed ID: 10975589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.
    Inagami T; Murakami T; Higuchi K; Nakajo S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):15S-22S. PubMed ID: 2009142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.